10-year CVD risk
1 paper1 finding
- Humans1
Associations
1Immunological non-response
upin humans1
1 study
Immunological non-response
upin humans1
Immunological non-response raises the risk of 10-year CVD risk in humans (11.86% vs 9.51%).
Humansin PLWH
Risk of Cardiovascular Disease Among People Living With HIV With Immunological Nonresponse
Journal of the International Association of Providers of AIDS Care11 Aug 2026
Latest
27 in 12 monthsJACC Advances
U.S. Trends in 10-Year Cardiovascular Risk Scores Over 2 Decades
Cross-sectional study of 26,980 peopleAtherosclerotic cardiovascular disease
BMC Cardiovascular Disorders
Association between the triglyceride-glucose-body mass index and the risk of early vascular aging in young and middle-aged Chinese adults: a cross-sectional study
Cross-sectional study of 1,272 peopleTriglyceride-glucose body mass index
International Journal of Preventive Medicine
Performance of Cardiovascular Disease (CVD) Risk Assessment Tools in Clinical Practice - Agreement Between Different CVD Risk Scores Among Patients Attending NCD Clinic in a Tertiary Care Setting: A Prospective Observational Study
Cohort study of 200 peopleCardiovascular disease
International Journal of Preventive Medicine
Integrating World Health Organization Package of Essential Noncommunicable Disease Interventions at Primary Health Care - An Impact Evaluation Study from a Mountainous State of India
Non-randomised trial in peopleNoncommunicable disease
International Journal of Prison Health
The health burden of incarceration: cardiovascular risk in a Nigerian prison population
Cross-sectional study of 180 peopleCardiovascular disease
Diabetes Care
Beyond Traditional Glycemic Measures: CGM Glycemic Profiles Reveal Associations With Cardiometabolic Risk in Individuals Without Diabetes
Cross-sectional study of 1,356 peopleBiomarkers
Indian Journal of Community Medicine
Decade of Risk: Predicting Ten-year Cardiovascular Disease Events (Stroke/myocardial Infarction) in Hypertensive Patients at a Tertiary Care Institute in Jharkhand
Cross-sectional study of 365 peopleMyocardial infarction
European Heart Journal
Development and external validation of the SCORE2 models in Latin America and the Caribbean (SCORE2-LAC) to estimate 10-year cardiovascular disease risk
Cohort study of 40,237,152 peopleCardiovascular disease